- Home
- PSKY vs CRL Comparison
PSKY vs CRL Comparison
Compare PSKY & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSKY
- CRL
- Stock Information
- Founded
- PSKY 1914
- CRL 1947
- Country
- PSKY United States
- CRL United States
- Employees
- PSKY N/A
- CRL N/A
- Industry
- PSKY Broadcasting
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PSKY Industrials
- CRL Health Care
- Exchange
- PSKY Nasdaq
- CRL Nasdaq
- Market Cap
- PSKY 7.1B
- CRL 7.1B
- IPO Year
- PSKY N/A
- CRL 2000
- Fundamental
- Price
- PSKY $10.12
- CRL $148.87
- Analyst Decision
- PSKY Sell
- CRL Buy
- Analyst Count
- PSKY 1
- CRL 14
- Target Price
- PSKY $8.00
- CRL $186.00
- AVG Volume (30 Days)
- PSKY 51.2M
- CRL 961.1K
- Earning Date
- PSKY 10-31-2025
- CRL 08-06-2025
- Dividend Yield
- PSKY N/A
- CRL N/A
- EPS Growth
- PSKY N/A
- CRL N/A
- EPS
- PSKY N/A
- CRL N/A
- Revenue
- PSKY $28,756,000,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- PSKY N/A
- CRL N/A
- Revenue Next Year
- PSKY N/A
- CRL $2.49
- P/E Ratio
- PSKY N/A
- CRL N/A
- Revenue Growth
- PSKY N/A
- CRL N/A
- 52 Week Low
- PSKY $9.96
- CRL $91.86
- 52 Week High
- PSKY $12.79
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- PSKY N/A
- CRL 37.64
- Support Level
- PSKY N/A
- CRL $161.82
- Resistance Level
- PSKY N/A
- CRL $168.61
- Average True Range (ATR)
- PSKY 0.00
- CRL 5.82
- MACD
- PSKY 0.00
- CRL -3.39
- Stochastic Oscillator
- PSKY 0.00
- CRL 7.31
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.